SEC Form 4 · accession 0001144204-19-000965
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bendheim
Officer — Exec. VP, Corporate Strategy · Director
Period of report
Jan 3, 2019
Accepted (ET)
Jan 7, 2019 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 3, 2019 | M | 2,500 | $11.83 | A | 2,500 | D | |
| Class A Common Stock | Jan 3, 2019 | S | 2,500 | $31.72 | D | 0 | D | |
| Class A Common Stock | Jan 4, 2019 | M | 2,500 | $11.83 | A | 2,500 | D | |
| Class A Common Stock | Jan 4, 2019 | S | 2,500 | $31.30 | D | 0 | D | |
| Class A Common Stock | Jan 7, 2019 | M | 2,500 | $11.83 | A | 2,500 | D | |
| Class A Common Stock | Jan 7, 2019 | S | 2,500 | $32.21 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Jan 3, 2019 | M | 2,500 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 2,500 | 14,890 | D |
| Option to purchase Common Stock | $11.83 | Jan 4, 2019 | M | 2,500 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 2,500 | 12,390 | D |
| Option to purchase Common Stock | $11.83 | Jan 7, 2019 | M | 2,500 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 2,500 | 9,890 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.